Irem Ilgezdi

Dr. Irem Ilgezdi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Turkish Journal of Cerebrovascular Diseases
Verified
Journal Article
Open access
IIIrem Ilgezdi
Irem Ilgezdi
LOLevent Ocek
Levent Ocek
LBLütfiye Asena Binyay
Lütfiye Asena Binyay
MÖMetin Murat Özçelik
Metin Murat Özçelik
BKBurak Kınalı
Burak Kınalı
YZYasar Zorlu
Yasar Zorlu
GİRİŞ ve AMAÇ: İskemik inme hastalarında gelişen serebral ödem mortalite ve morbiditenin en önemli nedenidir. Medikal tedaviye cevap alınamayan hastalarda dekompresif hemikraniyektomi yararlı olabilir. Bu yazıda, kliniğimizde akut iskemik inme nedeniyle dekompresif hemikraniyektomi uygulanan hastaların klinik özellikleri ve prognoz ile ilişkili faktörler değerlendirilmiştir. YÖNTEM ve GEREÇLER: Bu çalışmaya iskemik inme nedeni ile dekompresif hemikraniyektomi uygulanan 21 hasta alındı. Hastaların demografik özellikleri ile görüntüleme bulguları kaydedildi. Hastaların fonksiyonel durumu modifiye Rankin Skalası ile değerlendirildi. Hastanedeki izlem süresinde eksitus olan ve yaşayan hastaların klinik özellikleri ve görüntüleme bulguları karşılaştırıldı.BULGULAR: Çalışmaya 12’si erkek, 9’u kadın, yaş ortalaması 58.7±8.2 (46 - 78) olan 21 hasta alındı. Hastaların başvuru NIHSS skoru ortalaması 12.5±4.5 idi. İnfarkt 17 hastada orta serebral arter, 4 hastada internal karotis arter alanındaydı. Dekompresif hemikraniyektomi uygulama zamanı ortalama 2.9±2.5 gün ve hastanede ortalama kalış süresi 42.6±39.2 gün idi. Hastanedeki izlem süresinde beş (% 23.8) hasta eksitus oldu. Dekompresif hemikraniyektomi uygulanan hastalarda klinik özellikler ve görüntüleme bulguları mortalite ile ilişkili bulunmadı.TARTIŞMA ve SONUÇ: İskemik inmede dekompresif hemikraniyektomi medikal tedavi uygulanmasına rağmen kötüleşen hastalarda önemli bir tedavi seçeneğidir.

1 March 2024 in Archives Of Epilepsy
Verified
Journal Article
Closed access
HGHaşim Gezegen
Haşim Gezegen
IIIrem Ilgezdi
Irem Ilgezdi
TKTugba Kalayci
Tugba Kalayci
NŞNermin Görkem Şirin
Nermin Görkem Şirin
BKBirsen KARAMAN
Birsen KARAMAN
BBBetül Baykan
Betül Baykan

28 June 2022 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Closed access
PDF file
IIIrem Ilgezdi
Irem Ilgezdi
EIElif Ilgaz-Aydınlar
Elif Ilgaz-Aydınlar
PYPınar Yalınay-Dikmen
Pınar Yalınay-Dikmen
RSRamazan Sarı
Ramazan Sarı
İEİlhan Elmacı
İlhan Elmacı

12 May 2026 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
IIIrem Ilgezdi
Irem Ilgezdi
GAGulshan Aliyeva
Gulshan Aliyeva
NİNur Gülce İşkan
Nur Gülce İşkan
AEAyşe Deniz Elmalı
Ayşe Deniz Elmalı
NBNerses Bebek
Nerses Bebek
Hyperkinetic seizures (HSs), which are generally associated with the frontal lobe (although they may indeed originate from other regions too), are characterized by complex motor movements with high amplitude and short duration. To differentiate HSs originating from the frontal and extrafrontal lobes via electroencephalographic (EEG) features, notably timing. Clinical and video-EEG data of patients with HS were examined retrospectively. The localization of the ictal and interictal discharges, the onset and duration of the hyperkinetic movements, as well as the ictal-postictal electrophysiological and semiological features, were reviewed. The patients were divided into two groups according to their HS onset timing: if the onset of hyperkinetic semiology was in the first 10 seconds, they were classified as early-onset HS; if later, as late-onset HS. We included 29 patients (171 seizures); seizure onset was localized to the frontal region in 21 patients, and to the temporal and temporo-occipital regions in 6 patients, and it could not be determined in 2 patients. The HSs started in the early period in 21 patients, and in the late period in 8 patients; HSs originating from the frontal region started earlier than those originating from the temporal region (6.2 versus 25.7 seconds respectively; p = 0.002). Electrophysiological (35.4 versus 95.7 seconds respectively; p = 0.004) and clinical (34.3 versus 94.6 seconds respectively; p = 0.003) seizure durations were shorter in frontal-onset seizures compared with temporal-onset seizures. The timing of HS onset and the duration of the seizures are informative in terms of localization. Earlier onset of hyperkinetic semiology and shorter duration may point to a frontal origin.

20 June 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
IGIşil Yazici Gençdal
Işil Yazici Gençdal
NŞNermi̇n Görkem Şi̇rİn
Nermi̇n Görkem Şi̇rİn
IIIrem Ilgezdi
Irem Ilgezdi
ÜMÜmmü Mutlu
Ümmü Mutlu
EOEli̇f Kocasoy Orhan
Eli̇f Kocasoy Orhan
AÖAli̇ Emre Öge
Ali̇ Emre Öge
Background/aim: To investigate the diagnostic sensitivity of sural sensory nerve action potential (SNAP) to medial femoral cutaneous nerve and dorsal sural to sural SNAP amplitude ratios in patients with diabetic polyneuropathy. Materials and methods: Sural/radial (SRAR), sural/medial femoral cutaneous (SMFAR), and dorsal sural/sural (DSSAR) SNAP amplitude ratios were calculated in 22 controls and 46 patients with type 2 diabetes mellitus. Combined sensory scores (superficial peroneal, sural, dorsal sural, and medial plantar SNAPs), and amplitude ratio scores (SRAR, DSSAR, and SMFAR) were assessed. The parameters were compared statistically between the patient and control groups. Results: All SNAP amplitudes were significantly lower in patients as compared with those of the controls. Reduced medial plantar SNAP amplitude was the most frequent abnormality in the patient group. DSSAR and SMFAR, but not SRAR were found to have significant value in differentiating patients from controls with low sensitivity and moderate specificity. The combined sensory score improved the diagnostic accuracy for diabetic polyneuropathy, while the other combined scores add no additional value in this respect. Conclusion: Distal nerve conduction studies (NCSs) are most useful in diagnosing mild diabetic polyneuropathy. Although DSSAR and SMFAR can be moderately sensitive alternatives, particularly when used in combined scores, these ratios do not add any diagnosticvalue in patients with axonal polyneuropathies of similar severity.

25 February 2022
Verified
Book
Closed access
PDF file
KIKadir İlKkılıç
Kadir İlKkılıç
DADidar Yanardag Acik
Didar Yanardag Acik
OYOrhan Kemal Yücel
Orhan Kemal Yücel
YKYasin Kalpakçı
Yasin Kalpakçı
SBSevcan Tuğ Bozdoğan
Sevcan Tuğ Bozdoğan
ATAtakan Tekinalp
Atakan Tekinalp